from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3468c/-

LFCtreatmentdescriptionclass of inhibitor

0.050

Amikacinug/mL Amikacintranslation

-0.297

Cap5-10ug/mL Capreomycintranslation

-0.018

Rox10-50 ug/mL Roxithromycintranslation

1.055

SM2-5 ug/mL Streptomycintranslation

0.000

Tet5-10 ug/mL Tetracyclinetranslation

0.826

Rif0.2-5ug/mL Rifampicintranscription

-0.096

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.973

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.437

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.337

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.417

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.047

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.173

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.586

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.306

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.878

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.153

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.217

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.394

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.618

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

0.962

Nigericin50 uM Nigericinrespiration

-0.271

TRC10-150 ug/mL Triclosanrespiration

-0.090

TRZ10-25 ug/mL Thioridazinerespiration

-0.446

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.859

menadione6-10 ug/mL Menadionerespiration

-0.144

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.098

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.941

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.334

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.192

NRP_1Non-replicating persistence stage 1dosRassociated

0.034

Amp0.2mg/mL AmpicillincellWall

-0.279

Cephalexin20-100 ug/mL CephalexincellWall

0.908

Cerulenin0.32-5 ug/mL CerulenincellWall

0.148

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.097

EMB10-20 ug/mL EthambutolcellWall

-0.250

Eta12-40 ug/mL EthionamidecellWall

-0.239

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.068

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.517

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.764

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.725

BZA0.12 mg/mL BenzamidearomaticAmides

1.483

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.384

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.147

H2O24 mM hydrogen peroxideDNAdamaging

0.373

Levo10 ug/mL LevofloxacinDNAdamaging

1.052

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.343

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.689

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.390

UVUV-irradiationDNAdamaging

-0.562

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.223

Antimycin12.5-50 ug/mL Antimycin A?

-0.600

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.274

PA_110-50 ug/mL Antitubercular compound PA-1?

0.998

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.208

PA8240.2-2 ug/mL PA-824?

-0.429

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.211

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.416

Verapamil50 uM Verapamil?

-0.856

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.206

methoxatin10-20 ug/mL Methoxatin?